Best in Biotech 28 May 2024
8 Swedish companies spearheading the country’s biotech scene
As Sweden’s life sciences sector continues to grow, we explore 8 biotech companies in Sweden that are leading the way in the industry.
Karolinska Institutet
- Latest Posts
News and Trends 24 Mar 2023
Metabolism of RNA linked to leukemia
Researchers at Lund University Faculty of Medicine in Sweden have determined a novel mechanism linking the metabolism of ribonucleic acids, RNA, to the development of leukemia in myelodysplastic syndrome patients, MDS. In a study published in the Molecular Cell journal, they explain what makes hematopoietic stem cells acquire malignant traits in cancer. RNA splicing is […]
Best in Biotech 6 Mar 2023
10 universities around the world to study biotech you should know about
The biotech industry across the world has been picking up its pace over the years. As many sectors plummeted during the pandemic, the biotechnology industry weathered the storm. Global biopharma companies are collaborating with biotechnology universities across the globe to improve research and development in various fields within the industry. To boost business opportunities, universities […]
News and Trends 16 Feb 2023
Genetic study reveals high variation in T-cell receptor genes
T-cells are central in the protection against infections and cancer. With the help of TCRs (T-cell receptors), cells recognize foreign invaders and tumor cells. “It was previously unknown how variable human TCR genes are,” said Gunilla Karlsson Hedestam, professor at the department of microbiology, tumor and cell biology at Karolinska Institutet in Sweden, and the […]
News and Trends 7 Feb 2023
Antibody candidate for treating serious liver disease
There is currently no drug for treating non-alcoholic fatty liver disease, which affects many people with type 2 diabetes and which can result in other serious liver diseases. However, a new study led by researchers from Karolinska Institutet in Sweden has identified a drug candidate for the treatment of fatty liver. The preclinical study, published […]
More News! 24 Aug 2022
COVID-19 vaccine less sensitive to mutations being developed in Sweden
A new generation of coronavirus vaccine is being developed by Swedish researchers from the Karolinska Institutet. The vaccine is being specifically designed to be less sensitive to mutations and better equipped for any future strains. Promising results The vaccine showed promising results in mice in a newly published study in EMBO Molecular Medicine, and the researchers […]
ADVERTISEMENT
ADVERTISEMENT
News and Trends 30 Jan 2018
The Female Sex Hormone Estrogen Could Help to Fight Neuroblastoma
Estrogen receptors are switched off in aggressive cases of neuroblastoma so scientists have tested boosting estrogen activity to fight the disease. Researchers at the Karolinska Institutet in Stockholm have found that there could be a role for the female sex hormone estrogen in neuroblastoma, a form of cancer that tends to affect young children. The results […]
News and Trends 2 Jan 2017
An EU Project will tackle Multiple Sclerosis using Personalized Multi Omics
The MultipleMS Consortium has been granted €15M by the EU Horizon 2020 to improve the treatment of multiple sclerosis using personalized medicine. The EU Horizon 2020 has kicked off the year with a project to develop, validate, and exploit methods for the personalized treatment of multiple sclerosis (MS). The 21 institutions from 12 European countries and […]
News and Trends 5 Apr 2016
Interviewing one of the Leading Biotech Investors in Scandinavia
The Karolinska Institute (Sweden) is worldwide famous for giving the Nobel Prize every year… It’s also home of Karolinska Development, an investment company span out from Karolinska Institute. I had the chance to meet with Viktor Drvota, its Chief Investment Officer at BIO-Europe Spring 2016 in Stockholm. We had a chance to talk about the […]
News and Trends 10 Mar 2016
The Largest Scandinavian Biotech Fundraising of 2016 has just been Signed
Aprea (Sweden) is not a well-know Biotech (yet), but has succeeded in raising €46M from big investors in the US and Europe. Why? For its First-in-class potential for a famous cancer target… Aprea started in 2003 as a spin-off from cancer research at Karolinska Institutet, in its technology-transfer program. This Biotech has a promising candidate […]
News and Trends 7 Mar 2016
Swedish Investment loses €8M over failed Phase I/II for Leukemia
Akinion (Sweden) will stop the development of its candidate for leukemia, after patients in phase I/II have experienced liver toxicity. As a result, main investor Karolinska Development takes an €8M hit in its portfolio valuation. Sad news for Akinion. This Stockholm-based drug developer decided to halt the development of its lead candidate, APN-028. This happens after […]
News and Trends 20 Oct 2015
First-ever in utero Stem Cell Trial to be conducted by Karolinska Institutet
The Karolisnka Institutet (Sweden) is ready to make History by conducting the first study involving the transplantation of stem cells into unborn babies. The treatment aims to strengthen the bone by producing collagen in infants with the brittle-bone disease Osteogenesis imperfecta in utero. The study is to be coordinated by the Karolinska Institute but to […]
ADVERTISEMENT